Aster Dm Healthcare Limited (Asterdm) (NSE: ASTERDM, BSE: 540975) is a Bengaluru, Karnataka-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹58,702 Cr, it ranks #179 by market cap among the 6,137 Indian listed companies on FinBizNet, and #4 of 42 in Hospitals and Healthcare Centers. At ₹644.75 (as of 25 Oct 2026), the share price is 27.7% below its 52-week high of ₹891.30 and 24.2% above its 52-week low of ₹519.10. The share price is down 7.8% over one year and down 17.9% over three months.
| Current Price | ₹644.75 |
|---|---|
| Market Cap | ₹58,702 Cr |
| NSE Symbol | ASTERDM |
| BSE Code | 540975 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 88.7 |
| Return on Equity | 10.07% |
| Return on Assets | 5.45% |
| 52-Week Range | ₹519.10 – ₹891.30 |
| 1-Year Price Change | -7.8% |
| 3-Month Price Change | -17.9% |
| Beta (1Y) | 0.23 |
| Dividend Yield | 0.00% |
| Headquarters | Bengaluru, Karnataka |
| Website | www.asterdmhealthcare.in |
| Revenue | ₹1,311 Cr |
|---|---|
| Net Profit | ₹38 Cr |
| Net Margin | 2.9% |
| EPS (Basic) | ₹0.31 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India.
1. Hospitals-This segment operates hospitals and in-house pharmacies at the hospitals. 2. Clinics-This segment operates clinics and in-house pharmacies at the clinics. 3. Retail Pharmacies (Including Opticals)-This segment operates retail pharmacies and optical outlets. 4. Others-This segment provides healthcare consultancy services.
1. Hospitals & Clinics-97.1% 2. Labs-3.3% 3. Wholesale Pharmacies (Includes Retail Pharmacies and Opticals of GCC Business)-2.3% 4. Others-0.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Rainbow Children'S Medicare Limited | ₹12,685 Cr | 45.1 | 17.94% | ₹470 Cr | -11.6% |
Listed by market capitalisation. Ratios are shown for context only.
Aster Dm Healthcare Limited (Asterdm) is trading at ₹644.75, with a market capitalisation of ₹58,702 Cr.
Aster Dm Healthcare Limited (Asterdm) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Aster Dm Healthcare Limited (Asterdm) has a P/E of 88.7 and a return on equity of 10.07%.
Aster Dm Healthcare Limited (Asterdm) is listed on the NSE under the symbol ASTERDM and on the BSE under the scrip code 540975.
Aster Dm Healthcare Limited (Asterdm)'s share price is down 7.8% over one year and down 17.9% over three months. Its 52-week range is ₹519.10 to ₹891.30.
In Q1 FY27, Aster Dm Healthcare Limited (Asterdm) reported revenue of ₹1,311 Cr and net profit of ₹38 Cr, with basic EPS of ₹0.31 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.